Finance

Lists
Why is MBOT down 3.33%?
Dive Deeper
MBOT:NASDAQ
Microbot Medical Inc
$1.16
-3.33%
(-0.040) 1D
$1.16
-0.03% (-0.00030)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MBOT...
Open
$1.23
High
$1.23
Low
$1.14
Mkt. cap
77.91M
Avg. vol.
519.93K
Volume
852.40K
52-wk high
$3.46
52-wk low
$1.14
EPS
-$0.26
Beta
1.05
Shares outstanding
67.16M
No. of employees
43
Open
$1.23
High
$1.23
Low
$1.14
Mkt. cap
77.91M
Avg. vol.
519.93K
Volume
852.40K
52-wk high
$3.46
52-wk low
$1.14
EPS
-$0.26
Beta
1.05
Shares outstanding
67.16M
No. of employees
43
News stories
From web sources and news partners
About Microbot Medical Inc
CEO-
Employees43
FoundedAug 2, 1988
HeadquartersNewark, California, United States
SectorMedical device
Websitemicrobotmedical.com
Analyst ratings
Based on 3 analysts giving stock ratings to MBOT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MBOT in the last 3 months.
Highest
Current $1.16
$12.00 (+934.48%)
Average
$6.33 (+445.69%)
Lowest
$3.00 (+158.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Nowak
Lucid Capital
Buy
Maintained
$3.00
+158.6%
09/25/2026
William Wood
B. Riley Securities
Buy
Initiated
$4.00
+244.8%
09/11/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$12.00
+934.5%
08/20/2026
Unknown Analyst
Lucid Capital
Buy
Initiated
$4.00
+244.8%
06/03/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$5.50
+374.1%
04/14/2026
Anderson Schock
B. Riley Securities
Buy
Initiated
$5.00
+331%
02/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
105.00K
241.00K
Cost of goods sold
-
-
103.00K
884.00K
Cost of revenue
-
-
103.00K
884.00K
Research and development expenses
1.17M
1.27M
1.29M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.69M
2.87M
3.03M
3.68M
Operating expense
3.86M
4.14M
4.32M
5.54M
Total operating expenses
3.86M
4.14M
4.42M
6.43M
Operating income
-3.86M
-4.14M
-4.32M
-6.19M
Other non operating income
-
-
-
-
EBT including unusual items
-3.58M
-3.46M
-3.67M
-5.63M
EBT excluding unusual items
-3.58M
-3.46M
-3.67M
-5.63M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.58M
-3.46M
-3.67M
-5.63M
Net profit margin
-
-
-3,496.19%
-2,334.85%
Earnings per share
-0.07
-0.04
-0.05
-0.08
Interest and investment income
284.00K
674.00K
649.00K
561.00K
Interest expense
-
-
-
-
Net interest expenses
284.00K
674.00K
649.00K
561.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.85M
-4.13M
-4.31M
-6.17M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps